TrialJournal of the European Academy of Dermatology and Venereology : JEADV2016

Tofacitinib versus etanercept or placebo in patients with moderate to severe chronic plaque psoriasis: patient-reported outcomes from a Phase 3 study.

F Valenzuela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.